Filed Nov. 4, 2026

Serial No. 50200919

Examining Attorney null

Class Pharmaceutical agents affecting metabolism; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Ferments for pharmaceutical purposes; Phenol for pharmaceutical purposes; Digestives for pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating hypoglycemia; Diagnostic agents for pharmaceutical purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Intravenous bags sold filled with phenolic amides; Syringes sold filled with phenolic amides; Therapeutic pharmaceutical for the treatment of metabolic syndrome; Pharmaceutical preparations for the treatment of metabolic syndrome; Biologics in the nature of pharmaceutical preparations for the treatment of metabolic syndrome; Drug delivery agents in the form of oral supplements, injections, topical applications, or inhalation that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for the treatment of chronic diseases in the nature of liver disease; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Enzymes for medical purposes; Plant and herb extracts for medicinal purposes; 005; 006; 018; 044; 046; 051; 052

Case Type Trademark